CATAPANO, Francesco
 Distribuzione geografica
Continente #
EU - Europa 13.585
NA - Nord America 6.715
AS - Asia 4.700
SA - Sud America 858
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 64
OC - Oceania 25
AN - Antartide 1
Totale 26.099
Nazione #
RU - Federazione Russa 7.031
US - Stati Uniti d'America 6.629
IT - Italia 2.248
SG - Singapore 1.762
IE - Irlanda 1.257
UA - Ucraina 852
CN - Cina 851
HK - Hong Kong 795
BR - Brasile 739
GB - Regno Unito 562
VN - Vietnam 533
DE - Germania 478
FR - Francia 369
FI - Finlandia 218
SE - Svezia 204
JP - Giappone 181
TR - Turchia 165
GR - Grecia 158
IN - India 147
KR - Corea 100
NL - Olanda 49
CA - Canada 42
AR - Argentina 39
PL - Polonia 35
ID - Indonesia 28
ZA - Sudafrica 26
BE - Belgio 25
AU - Australia 24
EC - Ecuador 24
BD - Bangladesh 23
ES - Italia 21
IQ - Iraq 21
CH - Svizzera 18
AT - Austria 15
PY - Paraguay 14
CO - Colombia 13
MX - Messico 12
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
MY - Malesia 9
PE - Perù 9
PK - Pakistan 9
RO - Romania 9
DZ - Algeria 8
MA - Marocco 8
EG - Egitto 7
NP - Nepal 7
CZ - Repubblica Ceca 6
LT - Lituania 6
SA - Arabia Saudita 6
AL - Albania 5
EU - Europa 5
HN - Honduras 5
IL - Israele 5
KE - Kenya 5
IR - Iran 4
JO - Giordania 4
LB - Libano 4
NI - Nicaragua 4
PH - Filippine 4
RS - Serbia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KZ - Kazakistan 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
TW - Taiwan 3
BN - Brunei Darussalam 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 25.949
Città #
Moscow 2.442
Jacksonville 1.256
Dublin 1.248
Santa Clara 832
San Jose 805
Hong Kong 793
Singapore 607
Chandler 430
Ashburn 365
Princeton 224
Ho Chi Minh City 187
Roxbury 164
Medford 158
New York 147
Bremen 144
Rome 139
Beijing 134
Hanoi 116
Milan 114
Wilmington 105
Ann Arbor 104
Boardman 102
The Dalles 91
Seoul 89
Naples 80
Caserta 76
Cambridge 72
Bengaluru 70
Woodbridge 66
San Mateo 65
Dallas 64
São Paulo 59
Hefei 58
Fisciano 49
Aversa 44
Des Moines 41
Nanjing 41
Da Nang 33
Düsseldorf 33
Napoli 32
Catania 31
Los Angeles 30
Marigliano 30
Bologna 29
Florence 29
Jinan 27
Tokyo 27
Council Bluffs 24
Palermo 24
Atlanta 23
Houston 23
Seattle 23
Norwalk 22
Haiphong 21
Orem 21
Bari 20
Brasília 20
Munich 20
Memphis 19
Brooklyn 17
Brussels 17
Padova 17
Porto Alegre 17
Rio de Janeiro 17
Turin 17
Istanbul 15
Torino 15
Belo Horizonte 14
Nanchang 14
Nuremberg 14
San Prisco 14
Cagliari 13
Guangzhou 13
Hangzhou 13
Johannesburg 13
Parma 13
Radomsko 13
Shenyang 13
Chicago 12
Guayaquil 12
Mountain View 12
Sulzbach-Rosenberg 12
Vienna 12
Warsaw 12
Boston 11
Frankfurt am Main 11
Mumbai 11
Perugia 11
Redwood City 11
Tashkent 11
Tianjin 11
Athens 10
Auburn Hills 10
Biên Hòa 10
Chennai 10
Curitiba 10
Delhi 10
Denver 10
Helsinki 10
Montreal 10
Totale 12.660
Nome #
SINDROME METABOLICA E TRATTAMENTO CON ANTIPSICOTICI: DIFFERENZE IN PAZIENTI CON DIAGNOSI DI SCHIZOFRENIA E DISTURBO BIPOLARE 657
Discrasie ematiche transitorie e persistenti indotte dalla clozapina durante le prime diciotto settimane di trattamento 527
CLOZAPINA E ALTRI ANTIPSICOTICI ATIPICI E TIPICI: INCIDENZA E DECORSO DELLE DISCRASIE EMATICHE DURANTE LE PRIME DICIOTTO SETTIMANE DI TRATTAMENTO 271
[Critical evaluation of current diagnostic classification systems in psychiatry: the case of DSM-5] 250
“Decima revisione della classificazione internazionale delle sindromi e dei disturbi psichici e comportamentali-ICD10”- Criteri diagnostici per la ricerca. 243
Trattamento combinato con clorimipramina ed aripiprazolo nella depressione resistente 225
TRATTAMENTO CON ANTIPSICOTICI E COMPARSA DI SINDROME METABOLICA: UNO STUDIO RETROSPETTIVO IN PAZIENTI SCHIZOFRENICI E BIPOLARI 191
Burden on the families of patients with obsessive-compulsive disorder: a pilot study 177
ICD-10. Descrizioni cliniche e direttive diagnostiche 177
Brain natriuretic peptide as a biomarker of asymptomatic clozapine-related heart dysfunction: a criterion for a more cautious administration. 176
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study. 174
Duration of Untreated Illness in Patients with Obsessive-Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review 171
Decima revisione della classificazione internazionale delle sindromi e dei disturbi psichici e comportamentali-ICD10 166
Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study 165
La viloxazina: proprietà farmacologiche e profilo clinico di un antidepressivo di II generazione 165
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 161
Sindrome metabolica e utilizzo di antipsicotici in pazienti con diagnosi di schizofrenia e disturbo bipolare 159
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 159
Trattamento con antipsicotici e sindrome metabolica: uno studio retrospettivo in pazienti schizofrenici e bipolari 157
Organizational and Individual Interventions for Managing Work-Related Stress in Healthcare Professionals: A Systematic Review 156
A predictive model to allocate frequent service users of community-based Mental Health Service to different packages of care. 156
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 154
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 153
A neuropsychological study of obsessive-compulsive disorder 152
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 152
L’Olanzapina è più rapida dell’Aloperidolo nell’indurre Sindrome Metabolica in pazienti schizofrenici ma non nei bipolari 151
Aspetti biologici e terapia farmacologica dei disturbi ossessivo-compulsivi 149
Transient and persistent blood dyscrasias induced by clozapine during the first 18 weeks of treatment 149
Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients. 148
Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder 147
A hypothesis on Cotard’s syndrome as an evolution of obsessive-compulsive disorder 147
Antidepressivi nell'anziano 146
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 144
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasias 141
The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series. 141
Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders 140
Aspetti biologici della depressione 139
La depressione resistente al trattamento farmacologico: incremento dell’effetto antidepressivo della clorimipramina determinato dall’aripiprazolo 139
Use of coercive measures in mental health practice and its impact on outcome: a critical review. 138
Dimensioni sintomatologiche del disturbo ossessivo-compulsivo: caratteristiche cliniche e risposta al trattamento 138
Ansia 137
Circadian melatonin rhythm in patients with paranoid schizophrenia and obsessive-compulsive disorder 137
Studio di popolazione sulle conseguenze psicosociali di una catastrofe naturale: la frana di Sarno 136
Caratteristiche di personalità e stili criminali in un campione di detenuti minorenni 136
Il trattamento dei disturbi della personalità in soggetti detenuti 134
E' ancora manicomio: prima fase di un possibile progetto di intervento nell'Ospedale Psichiatrico 134
ICD-10. Criteri diagnostici per la ricerca 131
Shall psychiatry change its target? Reflections on the evolving role of psychiatry 131
Drug safety warnings in psychiatry: Adverse drug reactions' signaling from 2002 to 2014 131
Cortisol response to d-fenfluramine in drug-free patients with obsessive-compulsive disorder 130
Effetto dell'abuso di cannabis sulla durata della psicosi non trattata 130
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 129
Insight e resistenza nei pazienti ossessivi 129
Risposta al trattamento con inibitori del reuptake della serotonina nel disturbo ossessivo-compulsivo ad esordio precoce 128
Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study 126
Patient characteristics and symptoms associated with perceived coercion during hospital treatment 126
Metabolic Syndrome and Antipsychotic treatment: how about schizophrenia and bipolar disorder? 125
Obsessive-compulsive disorder: A 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. 124
I pazienti ossessivi con ridotto insight: caratteristiche cliniche e risposte al trattamento 124
L'antico Ospedale napoletano degli Incurabili e la pratica delle "battiture" 124
Pemphigus and skin disease: A comparison of the incidence of stressful life events and personality disorders 124
Neurocognitive indices of executive hypercontrol in obsessive-compulsive disorder 124
Gli ICD dell’Organizzazione Mondiale della Sanità 124
Urban insecurity and fear of crime in people suffering from mental disorders: a study in 24 Mental Health Centers in Italy 124
How do relatives cope with eating disorders? Results from an Italian multicentre study 124
Patterns assistenziali e outcome psicosociale in pazienti schizofrenici. Studio prospettivo triennale 123
Il trattamento dei disturbi della personalità in soggetti detenuti 123
Feasibility of a psychoeducational family intervention for people with bipolar I disorder and their relatives: Results from an Italian real-world multicentre study 123
Discrasie ematiche transitorie e persistenti e trattamento con clozapina nelle prime diciotto settimane di terapia 122
Duration of untreated illness and outcome of the OCD: a three-year prospective study 121
Proposal for a new funding system for mental health departments. Results from a evaluative multicentre Italian study (I-psycost) 120
The role of relatives in pathways to care of patients with a first episode of psychosis 120
Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study. 120
Reading Group Rehabilitation for Patients with Psychosis: A Randomized Controlled Study. 119
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 118
Fattori specifici e aspecifici della riabilitazione psicosociale (I parte) 118
Perceived insecurity, mental health and urbanization: Results from a multicentric study 118
Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia 117
Comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: Clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study 117
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder 116
ICD-10. Linne guida per la diagnosi e la gestione dei disturbi mentali nella medicina di base 116
La sindrome metabolica e l’utilizzo di antipsicotici: quali differenze in schizofrenia e disturbo bipolare? 115
Clozapine treatment and other atypical and typical antipsychotics: incidence and course of blood dyscrasias during the first eighteen weeks of treatment 115
La riabilitazione psicosociale. 115
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 115
Psychosocial consequences of the 1998 landslide in Sarno, Italy 113
Clozapine induces an early improvement of "disorganization" in a group of treatment resistant schizophrenic patients 113
What is the current status of training and practice of early intervention in psychiatry? Results from a survey in 35 countries 113
The relationship between obsessive-compulsive personality and obsessive-compulsive disorder: data obtained by the Personality Disorder Examination 112
Symptom dimensions and treatment response in obsessive-compulsive disorder 112
Valutazione del carico familiare in un campione di familiari di pazienti con sindrome ossessivo-compulsiva 112
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients 112
Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case Report 111
Obsessive-compulsive disorder with poor insight: clinical characteristics and treatment response 111
Schizofrenia e adattamento sociale: studio comparativo tra due strumenti di valutazione (S.A.S. e D.A.S.) 111
La sindrome bipolare a cicli rapidi: riproducibilità e validità di quattro definizioni alternative e loro implicazioni cliniche 110
Vecchi scenari e nuove prospettive della riabilitazione psicosociale: fattori terapeutici e neuroplasticità 110
L'ansia , la depressione e il movimento nell'anziano 110
Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia 109
Durata di psicosi non trattata, durata di malattia non trattata e pathways to care negli esordi psicotici 109
Totale 14.712
Categoria #
all - tutte 84.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.301 0 6 31 36 491 8 16 66 62 58 117 410
2022/20232.227 245 65 34 124 286 173 4 116 1.071 21 46 42
2023/20241.212 67 20 38 128 377 106 38 37 18 35 121 227
2024/20253.322 25 60 63 90 505 403 367 268 417 723 226 175
2025/202612.101 386 444 562 649 871 6.603 782 514 552 407 180 151
2026/2027446 147 299 0 0 0 0 0 0 0 0 0 0
Totale 26.099